台灣子宮頸癌的流行病學與治療現況：2001~2018

Epidemiology and treatment of cervical cancer in Taiwan: 2001~2018

台灣子宮頸癌自民國84年開始推動全國子宮頸癌篩檢後，已達相當成果：2018年子宮頸癌年齡標準化發生率已降至7.87（每十萬女性）、年齡標準化死亡率已降至2.93（每十萬女性），5年存活率也具一定水準；但逐年下降的子宮頸篩檢率、25-29歲女性子宮頸癌發生率的升高、與隨年齡增高而逐漸攀升的粗發生率，正延緩子宮頸癌防治的進展，藉由發現這些問題，可協助醫療團隊針對目標族群強化篩檢，同時配合國家癌症防治計畫的持續推展，加上人類乳突疫苗的擴大施打，期望於未來有效控制子宮頸癌對女性的危害。

Taiwan began to promote national cervical cancer screening since 1984, cervical cancer has reached a positive result: in 2018, the age-adjusted incidence of cervical cancer has been reduced to 7.87 (per 100,000 females), the ageadjusted mortality rate has been reduced to 2.93 (per 100,000 females), and the 5-year survival rate has also reached an expected level. However, the year-onyear decline in the screening rate, the increase in the incidence rate of cervical cancer for females between the ages of 25-29 years, and the gradual increase in the crude incidence rate as age increases, are delaying the progress of cervical cancer prevention and treatment. By identifying these problems, it can help the medical teams to strengthen screening for the target groups, to cooperate with the continuous promotion of the National Cancer Prevention and Control Program, as well as to expand the administration of the HPV vaccine, so that we hope to effectively control the harms caused by cervical cancer to women in the future.